We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
Painchek is eyeing a market of 1.7 million US aged-care beds for its pain-detection device Genetic...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleMoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We...
Read ArticleThis article is part of the daily news updates from FNArena.com. Stay informed with the latest finan...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleNow could be the time to pounce on one small cap ASX stock if your risk tolerance allows for it. Tha...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleFor biotech investors, the news of an approval by the US FDA is a genuinely exciting milestone. The...
Read ArticleMolecular diagnostics company Genetic Signatures (ASX:GSS) has announced that the US FDA has...
Read ArticleAussie shares down on weaker commodities Iron ore and energy stocks slip, while goldies gain Intel...
Read ArticleIt was a tough start to the week for the St Barbara Ltd (ASX: SBM) share price. The ASX gold stock w...
Read ArticleASX in broad rebound; Cettire, Neuren, and Lendlease lead surge Positive sentiment follows Wall Str...
Read ArticleBy now, all Australians would be aware of the woes that high inflation has brought upon us. After vi...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a decent gain. At...
Read ArticleEMVision’s AI algorithm shows promise EMvision Medical Devices (ASX:EMV) has shared an update from i...
Read ArticleStock market crashes can cause a lot of pain when they do occasionally occur. When a crash happens,...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleThe ASX staged a relief rally on Monday Gold, oil stocks struggled after tensions in the Middle Eas...
Read ArticleGenetic Signatures (ASX:GSS) shares were down -1.45% to 68cps on Monday, even as the company reporte...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleWelcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Metals ((AX1)) - Ac...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleWorld Overnight SPI Overnight 7046.00 – 24.00 – 0.34% S&P ASX 200 7038.20 – 38.30 – 0.54%...
Read ArticleWorld Overnight SPI Overnight 7111.00 – 7.00 – 0.10% S&P ASX 200 7076.50 + 7.70 0.11% S&...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes and updates...
Read ArticleBy Rudi Filapek-Vandyck, Editor FNArena Guide: The FNArena database tabulates the views of eight maj...
Read ArticleIf you have a high tolerance for risk, then read on! That's because Bell Potter has just upgraded t...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes and updates...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleAustralian molecular diagnostics company Genetic Signatures has submitted an application to...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleGenetic Signatures jumps on FDA 510(k) application Allegra says FDA has questions related to its 51...
Read ArticleFutures indicate the ASX200 will open slightly higher as a new trading week commences, driven by gro...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleFutures predict the ASX will open lower to finish the week, triggered by tech shares losing momentum...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleDr John Melki – CEO and Director – Genetic Signatures (ASX:GSS) is transforming molecular diagnost...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleWhilst the prevalence of Artificial intelligence has boosted the US-tech sector, with the likes of N...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleAustco Healthcare wins St Paul’s Hospital in Canada worth $7.4m Next Science announced a new CEO AV...
Read ArticleThe infectious diseases space is one area that could be interesting for ethical investors An ASX co...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleGSS’s share price could almost triple, according to Taylor Collison Taylor also believes Good Drink...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleThe long and short of 2022 is that it was a frustrating period for the Australian biotech sector but...
Read ArticleShareCafeWebinar Recap – T92, GSS, ORR & SPT Catch up on the full webinar with presentations fr...
Read ArticleShareCafeGenetic Signatures (ASX: GSS) – webinar presentation John Melki – CEO and Director – Genet...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleShareCafeThe Week that Was: November 14-18, 2022 We at ShareCafe understand you are busy and may not...
Read ArticleShareCafeGenetic Signatures (ASX: GSS) – Detecting Infectious Diseases in High-Throughput Lab Workfl...
Read ArticleASX 200 closes with -1.8% loss Small cap index down -1.2% Up way more than 100% is Norfolk Minerals...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleAs Maxwell Smart said: “Missed it by that much.” In Genetic Signatures’ (ASX:GSS) case, the close-bu...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleNasdaq-listed Biogen says its experimental Alzheimer’s drug study was successful The news sends ASX...
Read ArticleMolecular diagnostics company Genetic Signatures (ASX:GSS) has completed recruitment for the...
Read ArticleGenetic Signatures (GSS) completes recruitment for its 3base EasyScreen enteric protozoan diagnosti...
Read ArticleINOVIQ reports good findings from feasibility study Mayne Pharma launches a unique oral contracepti...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleGenetic Signatures (ASX:GSS) has announced a three-year contract to supply its EasyScreen ge...
Read ArticleGenetic Signatures (GSS) has secured a three-year contract with Public Health Wales, worth up to $1...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleIn this week’s ScoPo’s Powerplays, healthcare and life sciences expert Scott Power, who has been a s...
Read ArticleShareCafeGenetic Signatures (ASX: GSS) – Webinar Presentation John Melki – CEO & Director – Ge...
Read ArticleShareCafeWebinar Recap – GSS, LGP, ALA & RTH Catch up on the full webinar with presentat...
Read ArticleAt the time of writing, the ASX 200 Health Index (XHJ) is down by 2.3%, while the benchmark ASX 200...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAustralia’s Therapeutic Goods Administration (TGA) registers a saliva-based protocol for testing sa...
Read ArticleIn afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a decl...
Read ArticleThe Genetic Signatures Ltd (ASX: GSS) share price is on the move today after an update on the compa...
Read ArticleAmong ASX health stocks with news, Genetic Signatures (ASX:GSS) caught the market’s attention with a...
Read ArticleASX investors evidently shrugged off omicron fears in December, with the last month of the 2021 bein...
Read ArticleShares in molecular diagnostics company Genetic Signatures Ltd (ASX: GSS) finished the day strong a...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleGenetic Signatures (GSS) has released a wide-ranging update, revealing it’s expecting $21 million d...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleShareCafeHidden Gems Webinar Recap – BPH, EX1, RAP & PTX Catch up on the full webinar with pres...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleShareCafeHidden Gems Webinar Recap – PHL, LBY, BCB & GSS Catch up on the full webinar with pres...
Read ArticleShareCafeTest kits for infectious disease John Melki – CEO & Director – Genetic Signatures is a...
Read ArticleShareCafeGenetic Signatures: Australia’s Rapid Growth Diagnostics Company by Colin Hay Genetic Sig...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleSummary Trajan Group Holdings made a strong debut on ASX on June 7, 2021. The MedTech company s...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleSummary Several ASX-listed companies have released their quarterly results in the last few days,...
Read ArticleSummary Medicinal cannabis player MGC Pharmaceuticals has a historic quarter with the ground-bre...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleShareCafeThe Week that Was – March 1-5, 2021 We at ShareCafe understand you are busy and may not hav...
Read ArticleShareCafeGenetic Signatures Leverages New Screening Targets to EU and US Markets Following the annou...
Read ArticleCOVID-19 vaccines have reached Australia but ASX stocks that were making anti-COVID 19 drugs or test...
Read ArticleThe Genetic Signatures Ltd (ASX: GSS) share price was on form on Monday. At one stage the molecular...
Read ArticleShareCafeGenetic Signatures (ASX:GSS) – Hidden Gems Webinar Presentation – 12/2/21 Presenter – Jo...
Read ArticleShareCafeHidden Gems Webinar Recap – Chester Asset Management, GSS, SVL, BPH – 12/2/21 Catch up on...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes for ASX-lis...
Read ArticleThe Genetic Signatures Ltd (ASX: GSS) share price has been pushing higher with the market today. In...
Read ArticleSummary Genetic Signatures has acquired Boston Medical Center (BMC) for the supply of its SARS-C...
Read ArticleThe Genetic Signatures Ltd (ASX: GSS) share price is rocketing higher on Wednesday after the releas...
Read ArticleThe market may be struggling on Thursday, but that hasn’t stopped the Genetic Signatures Ltd (ASX:...
Read ArticleIn late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to end the week on a disapp...
Read ArticleShareCafeGenetic Signatures – ShareCafe Hidden Gems Webinar Presentation Presenter – John Melki –...
Read ArticleShareCafeHidden Gems Webinar Recap – OSL, MDC, CYP, GSS We continue to unearth small-cap companie...
Read ArticleBy Tim Boreham, Editor, The New Criterion The ASX biotechs surfing the COVID-19 story Normally inves...
Read ArticleNormally investors shun speculative plays in times of market uncertainties, but that’s not been the...
Read ArticleTwo COVID-19 antibody kits have failed post-market testing, raising more questions about the 20 poin...
Read ArticleLess than a fortnight ago Finfeed noted Genetic Signature Ltd’s (ASX: GSS) news that it had suppleme...
Read ArticleThis could be the best investment opportunity that Australian investors have had in a decade. Those...
Read ArticleA new rapid testing kit that can detect the virus which causes Covid-19 has been given the tick of a...
Read ArticleAustralian biotech Genetic Signatures’ (ASX:GSS) is now able to start selling its recently developed...
Read Article14 Apr 2020 - Genetic Signatures (ASX:GSS) has received notice from the Therapeutic Goods Administra...
Read ArticleAn additional news report on the recommendation, valuation, forecast and opinion changes for ASX-lis...
Read ArticleThe market for COVID-19 diagnostic kits is much broader than just the health sector, as miners and o...
Read ArticleEach Monday, Stockhead recaps which stocks are most heavily in demand by investors — running hot. Th...
Read ArticleSpecialist molecular diagnostics company Genetic Signatures (ASX: GSS) is sending its first shipment...
Read ArticleShares in Genetic Signatures Limited (ASX:GSS) were up 50% at one stage on Monday morning as managem...
Read ArticleMolecular diagnostics company Genetic Signatures (ASX: GSS) has submitted a European CE in vitro dia...
Read ArticleAs with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time atta...
Read ArticleAs the coronavirus death toll rises to more than 1,000 and the World Health Organisation labels it a...
Read ArticleThe Aussie market wavers around yesterdays closing mark, following marginal shifts in US indices ove...
Read ArticleWe hate to sound like an old school report, but it’s been a year of steady and solid progress for th...
Read ArticleAs the saying goes, if you can make it in New York you can make it anywhere. But for the home-grown...
Read ArticleHealth care sector During the past several years, the Australian Health Care Sector had seen rapid d...
Read ArticleThis year has been a positive one for ASX small caps. According to Bloomberg, the average small cap...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
